Chang K-K, Liu L-B, Jin L-P, Meng Y-H, Shao J, Wang Y, et al
Progressive overload that follows adaptation: as you get stronger, add weight or reps
F-bio-HJ triggers starvation protection in macrophages via glucose oxidase to reduce cellular ferroptosis while accelerating Fe delivery to bacteria (both extracellularly and intracellularly) to induce bacterial ferroptosis
Fundoscopy included assessment of absence or presence of papilledema and secondary optic atrophy
Doctors respect patients who've done their homework and engage in collaborative decision-making rather than demand-based requests
According to the IFEBP survey, the top 10 factors when considering covering GLP-1 drugs for obesity are: Obesity as a risk factor for chronic diseases and associated costs Drug shortages Impact/effectiveness of cost-control mechanisms Existing coverage through government programs Long-term costs Patient and prescriber demand Broker/consultant/ PBM recommendations Lack of long-term use clinical studies of GLP-1 drugs Side effects Similar drugs in research and development The cost of these drugs can range from a minimum of $200 to $300 a month, and this cost would stretch over a long period of time, as GLP-1 drugs for weight loss require prolonged use, Bajaj said
